LRI+Pilots+Tests+Performed

include component="page" wikiName="siframework" page="LRI Header"

LRI Pilots Tests Performed (Draft)
"F" = Fail LRI Validation "ND" = Not done "LOINCs tested" = LOINC Code(s) actually used in testing ||  ||   || //P/F/ND//
 * **No** || **No/185**
 * Vocab**
 * WG**
 * [|list]** || **Class** || **Test**
 * Example** || **LOINC**
 * Example** || **[|Rank] of**
 * LOINC**
 * Example**
 * (/2000)** || **Team 1**
 * LabLynx** || **Team 2**
 * Atlas**
 * Development** || **Team 3**
 * Halfpenny**
 * Technologies** || **Team 4**
 * KHIE** || **Team 5**
 * CAP** || **Team 6**
 * Cerner**
 * Millennium** ||
 * ||  ||   || "P" = Pass LRI Validation

//LOINCs// //tested// || //P/F/ND//

//LOINCs// //tested// || //P/F/ND//

//LOINCs// //tested// || //P/F/ND//

//LOINCs// //tested// || //P/F/ND//

//LOINCs// //tested// || //P/F/ND//

//LOINCs// //tested// ||
 * 1 || 1 || Chemistry || Troponin I.cardiac [Mass/volume] || [|10839-9] || 113 ||  ||   ||   ||   ||   ||   ||
 * 2 || 2 || Chemistry || Protein [Mass/volume] || [|2885-2] || 22 ||  ||   ||   ||   ||   ||   ||
 * 3 || 3 || Chemistry || Albumin [Mass/volume] || [|1751-7] || 20 ||  ||   ||   ||   ||   ||   ||
 * 4 || 4 || Chemistry || Globulin [Mass/volume] || [|10834-0] || 62 ||  ||   ||   ||   ||   ||   ||
 * 5 || 5 || Chemistry || Urea nitrogen [Mass/volume] || [|3094-0] || 6 ||  ||   ||   ||   ||   ||   ||
 * 6 || 6 || Chemistry || Creatinine [Mass/volume] || [|2160-0] || 1 ||  ||   ||   ||   ||   ||   ||
 * 7 || 7 || Chemistry || Alkaline phosphatase [Enzymatic activity/volume] || [|6768-6] || 23 ||  ||   ||   ||   ||   ||   ||
 * 8 || 8 || Chemistry || Alanine aminotransferase [Enzymatic activity/volume] || [|1742-6] || 16 ||  ||   ||   ||   ||   ||   ||
 * 9 || 9 || Chemistry || Aspartate aminotransferase [Enzymatic activity/volume] || [|1920-8] || 19 ||  ||   ||   ||   ||   ||   ||
 * 10 || 10 || Chemistry || Calcium [Mass/volume] || [|17861-6] || 12 ||  ||   ||   ||   ||   ||   ||   ||
 * 11 || 11 || Chemistry || Sodium [Moles/volume] || [|2951-2] || 5 ||  ||   ||   ||   ||   ||   ||
 * 12 || 12 || Chemistry || Potassium [Moles/volume] || [|2823-3] || 3 ||  ||   ||   ||   ||   ||   ||
 * 13 || 13 || Chemistry || Chloride [Moles/volume] || [|2075-0] || 8 ||  ||   ||   ||   ||   ||   ||
 * 14 || 14 || Chemistry || Carbon dioxide, total [Moles/volume] || [|2028-9] || 7 ||  ||   ||   ||   ||   ||   ||
 * 15 || 15 || Chemistry || Glucose [Mass/volume] || [|2345-7] || 4 ||  ||   ||   ||   ||   ||   ||
 * 16 || 16 || Chemistry || Bilirubin [Mass/volume] || [|1978-6] || 171 ||  ||   ||   ||   ||   ||   ||
 * 17 || 17 || Chemistry || Bilirubin.direct [Mass/volume] || [|1968-7] || 82 ||  ||   ||   ||   ||   ||   ||
 * 18 || 18 || Chemistry || Glomerular filtration rate/1.73 sq M.predicted by Creatinine-based formula || [|33914-3] || 26 ||  ||   ||   ||   ||   ||   ||
 * 19 || 19 || Chemistry || Cholesterol [Mass/volume] || [|2093-3] || 32 ||  ||   ||   ||   ||   ||   ||
 * 20 || 20 || Chemistry || Triglyceride [Mass/volume] || [|2571-8] || 36 ||  ||   ||   ||   ||   ||   ||
 * 21 || 21 || Chemistry || Cholesterol in HDL [Mass/volume] || [|2085-9] || 38 ||  ||   ||   ||   ||   ||   ||
 * 22 || 22 || Chemistry || Cholesterol in LDL [Mass/volume] || [|13457-7] || 63 ||  ||   ||   ||   ||   ||   ||
 * 23 || 23 || Chemistry || Phosphate [Mass/volume] || [|2777-1] || 69 ||  ||   ||   ||   ||   ||   ||
 * 24 || 24 || Chemistry || Urate [Mass/volume] || [|3084-1] || 142 ||  ||   ||   ||   ||   ||   ||
 * 25 || 25 || Chemistry || C Reactive Protein [Mass/volume] || [|1988-5] || 154 ||  ||   ||   ||   ||   ||   ||
 * 26 || 26 || Chemistry || Amylase [Enzymatic activity/volume] || [|1798-8] || 152 ||  ||   ||   ||   ||   ||   ||
 * 27 || 27 || Chemistry || Lipase [Enzymatic activity/volume] || [|3040-3] || 139 ||  ||   ||   ||   ||   ||   ||
 * 28 || 28 || Chemistry || Folate [Mass/volume] || [|2284-8] || 181 ||  ||   ||   ||   ||   ||   ||
 * 29 || 29 || Chemistry || Calcidiol [Mass/volume] || [|1989-3] || 127 ||  ||   ||   ||   ||   ||   ||
 * 30 || 30 || Chemistry || Cobalamin (Vitamin B12) [Mass/volume] || [|2132-9] || 150 ||  ||   ||   ||   ||   ||   ||
 * 31 || 31 || Chemistry || Ferritin [Mass/volume] || [|2276-4] || 153 ||  ||   ||   ||   ||   ||   ||
 * 32 || 32 || Chemistry || Iron [Mass/volume] || [|2498-4] || 140 ||  ||   ||   ||   ||   ||   ||
 * 33 || 33 || Chemistry || Iron binding capacity [Mass/volume] || [|2500-7] || 157 ||  ||   ||   ||   ||   ||   ||
 * 34 || 34 || Chemistry || Iron binding capacity.unsaturated [Mass/volume] || [|2501-5] || 221 ||  ||   ||   ||   ||   ||   ||
 * 35 || 35 || Chemistry || Iron saturation [Mass Fraction] || [|2502-3] || 192 ||  ||   ||   ||   ||   ||   ||
 * 36 || 36 || Chemistry || IgA [Mass/volume] || [|2458-8] || 220 ||  ||   ||   ||   ||   ||   ||
 * 37 || 37 || Chemistry || IgG [Mass/volume] || [|2465-3] || 241 ||  ||   ||   ||   ||   ||   ||
 * 38 || 38 || Chemistry || IgM [Mass/volume] || [|2472-9] || 263 ||  ||   ||   ||   ||   ||   ||
 * 39 || 39 || Chemistry || Gamma glutamyl transferase [Enzymatic activity/volume] || [|2324-2] || 190 ||  ||   ||   ||   ||   ||   ||
 * 40 || 40 || Chemistry || Lactate dehydrogenase [Enzymatic activity/volume] || [|2532-0] || 156 ||  ||   ||   ||   ||   ||   ||
 * 41 || 41 || Chemistry || Creatine kinase [Enzymatic activity/volume] || [|2157-6] || 90 ||  ||   ||   ||   ||   ||   ||
 * 42 || 42 || Chemistry || Creatine kinase.MB [Mass/volume] || [|13969-1] || 111 ||  ||   ||   ||   ||   ||   ||
 * 43 || 43 || Chemistry || Estradiol (E2) [Mass/volume] || [|2243-4] || 231 ||  ||   ||   ||   ||   ||   ||
 * 44 || 44 || Chemistry || Follitropin [Units/volume] || [|15067-2] || 230 ||  ||   ||   ||   ||   ||   ||
 * 45 || 45 || Chemistry || Prolactin [Mass/volume] || [|2842-3] || 290 ||  ||   ||   ||   ||   ||   ||
 * 46 || 46 || Chemistry || Lutropin [Units/volume] || [|10501-5] || 271 ||  ||   ||   ||   ||   ||   ||
 * 47 || 47 || Chemistry || Testosterone [Mass/volume] || [|2986-8] || 203 ||  ||   ||   ||   ||   ||   ||
 * 48 || 48 || Chemistry || Prostate specific Ag [Mass/volume] || [|2857-1] || 124 ||  ||   ||   ||   ||   ||   ||
 * 49 || 49 || Chemistry || Natriuretic peptide B [Mass/volume] || [|30934-4] || 204 ||  ||   ||   ||   ||   ||   ||
 * 50 || 50 || Chemistry || Magnesium [Mass/volume] || [|19123-9] || 94 ||  ||   ||   ||   ||   ||   ||
 * 51 || 51 || Chemistry || Hemoglobin A1c/Hemoglobin.total || [|4548-4] || 81 ||  ||   ||   ||   ||   ||   ||
 * 52 || 52 || Chemistry || Triiodothyronine (T3) Free [Mass/volume] || [|3051-0] || 274 ||  ||   ||   ||   ||   ||   ||
 * 53 || 53 || Chemistry || Thyroxine (T4) free [Mass/volume] || [|3024-7] || 133 ||  ||   ||   ||   ||   ||   ||
 * 54 || 54 || Chemistry || Triiodothyronine (T3) [Mass/volume] || [|3053-6] || 223 ||  ||   ||   ||   ||   ||   ||
 * 55 || 55 || Chemistry || Triiodothyronine resin uptake || [|3050-2] || 200 ||  ||   ||   ||   ||   ||   ||
 * 56 || 56 || Chemistry || Thyroxine (T4) [Mass/volume] || [|3026-2] || 145 ||  ||   ||   ||   ||   ||   ||
 * 57 || 57 || Chemistry || Thyrotropin [Units/volume] || [|11579-0] || 75 ||  ||   ||   ||   ||   ||   ||
 * 58 || 58 || Chemistry || Choriogonadotropin (pregnancy test) [Presence] || [|2106-3] || 184 ||  ||   ||   ||   ||   ||   ||
 * 59 || 59 || Chemistry || Calcium.ionized [Moles/volume] || [|1994-3] || 130 ||  ||   ||   ||   ||   ||   ||
 * 60 || 60 || Anatomic Path (AP) || Surgical pathology study || [|11529-5] || 209 ||  ||   ||   ||   ||   ||   ||
 * 61 || 61 || Blood Bank || ABO group [Type] || [|883-9] || 218 ||  ||   ||   ||   ||   ||   ||
 * 62 || 62 || Blood Bank || Rh [Type] || [|10331-7] || 255 ||  ||   ||   ||   ||   ||   ||
 * 63 || 63 || Blood Bank || Blood group antibody screen [Presence] || [|890-4] || 198 ||  ||   ||   ||   ||   ||   ||
 * 64 || 64 || Coagulation || Activated partial thrombplastin time (aPTT) in Platelet poor plasma || [|14979-9] || 147 ||  ||   ||   ||   ||   ||   ||
 * 65 || 65 || Coagulation || Fibrinogen [Mass/volume] in Platelet poor plasma || [|3255-7] || 267 ||  ||   ||   ||   ||   ||   ||
 * 66 || 66 || Coagulation || Prothrombin time (PT) in Platelet poor plasma || [|5902-2] || 47 ||  ||   ||   ||   ||   ||   ||
 * 67 || 67 || Coagulation || INR in Platelet poor plasma || [|6301-6] || 53 ||  ||   ||   ||   ||   ||   ||
 * 68 || 68 || Cytology || Specimen source [Identifier] in Cervical or vaginal smear or scraping by Cyto stain || [|19763-2] || 110 ||  ||   ||   ||   ||   ||   ||
 * 69 || 69 || Cytology || Cytology report of Cervical or vaginal smear or scraping Cyto stain.thin prep || [|47527-7] || 85 ||  ||   ||   ||   ||   ||   ||
 * 70 || 70 || Cytology || Recommended follow-up [Identifier] in Cervical or vaginal smear or scraping by Cyto stain || [|19773-1] || 114 ||  ||   ||   ||   ||   ||   ||
 * 71 || 71 || Cytology || Cytology study comment Cervical or vaginal smear or scraping Cyto stain || [|19774-9] || 945 ||  ||   ||   ||   ||   ||   ||
 * 72 || 72-80 || Hematology || Complete blood count (hemogram) panel in Blood || [|58410-2] || 7(orders) ||  ||   ||   ||   ||   ||   ||
 * 73 || 81-99 || Hematology || CBC with Ordered Manual Differential panel in Blood || [|57782-5] || 6(orders) ||  ||   ||   ||   ||   ||   ||
 * 74 || 100 || Hematology || Erythrocyte sedimentation rate || [|4537-7] || 137 ||  ||   ||   ||   ||   ||   ||
 * 75 || 101 || Hematology || Reticulocytes/100 erythrocytes in Blood || [|4679-7] || 281 ||  ||   ||   ||   ||   ||   ||
 * 76 || 102 || Hepatitis || Hepatitis A virus IgM Ab [Presence] || [|13950-1] || 319 ||  ||   ||   ||   ||   ||   ||
 * 77 || 103 || Hepatitis || Hepatitis B virus core IgM Ab [Presence] || [|24113-3] || 353 ||  ||   ||   ||   ||   ||   ||
 * 78 || 104 || Hepatitis || Hepatitis B virus surface Ag [Presence] || [|5196-1] || 210 ||  ||   ||   ||   ||   ||   ||
 * 79 || 105 || Hepatitis || Hepatitis C virus Ab [Presence] || [|13955-0] || 395 ||  ||   ||   ||   ||   ||   ||
 * 80 || 106 || Hepatitis || Hepatitis A virus Ab [Units/volume] || [|5183-9] || 1176 ||  ||   ||   ||   ||   ||   ||
 * 81 || 107 || Hepatitis || Hepatitis B virus core Ab [Units/volume] || [|5187-0] || 989 ||  ||   ||   ||   ||   ||   ||
 * 82 || 108 || Hepatitis || Hepatitis B virus surface Ab [Units/volume] || [|5194-6] || 335 ||  ||   ||   ||   ||   ||   ||
 * 83 || 109 || Hepatitis || Hepatitis C virus Ab [Units/volume] || [|5198-7] || 239 ||  ||   ||   ||   ||   ||   ||
 * 84 || 110 || Hepatitis || Hepatitis C virus Ab Signal/Cutoff [Ratio] || [|51656-7] || 280 ||  ||   ||   ||   ||   ||   ||
 * 85 || 111 || Hepatitis || Hepatitis C virus genotype [Identifier] || [|32286-7] || 842 ||  ||   ||   ||   ||   ||   ||
 * 86 || 112 || Toxicology || Lead [Mass/volume] || [|5671-3] || 266 ||  ||   ||   ||   ||   ||   ||
 * 87 || 113 || Toxicology || Tacrolimus [Mass/volume] || [|11253-2] || 216 ||  ||   ||   ||   ||   ||   ||
 * 88 || 114 || Toxicology || Amphetamines [Presence] in Urine || [|3349-8] || 214 ||  ||   ||   ||   ||   ||   ||
 * 89 || 115 || Toxicology || Cannabinoids [Presence] in Urine || [|18282-4] || 224 ||  ||   ||   ||   ||   ||   ||
 * 90 || 116 || Toxicology || Cocaine [Presence] in Urine || [|3397-7] || 301 ||  ||   ||   ||   ||   ||   ||
 * 91 || 117 || Toxicology || Opiates [Presence] in Urine || [|3879-4] || 195 ||  ||   ||   ||   ||   ||   ||
 * 92 || 118 || Toxicology || Phencyclidine [Presence] in Urine || [|19659-2] || 273 ||  ||   ||   ||   ||   ||   ||
 * 93 || 119 || Genetics || CFTR gene mutations found [Identifier] || [|21654-9] || 460 ||  ||   ||   ||   ||   ||   ||
 * 94 || 120 || Microbiology || HIV 1 Ab [Presence] || [|29893-5] || 1177 ||  ||   ||   ||   ||   ||   ||
 * 95 || 121 || Microbiology || HIV 1+2 Ab [Presence] || [|31201-7] || 324 ||  ||   ||   ||   ||   ||   ||
 * 96 || 122 || Microbiology || HIV 1 RNA [Presence] || [|25835-0] || 1661 ||  ||   ||   ||   ||   ||   ||
 * 97 || 123 || Microbiology || HIV genotype [Susceptibility] || [|49573-9] || 1188 ||  ||   ||   ||   ||   ||   ||
 * 98 || 124 || Microbiology || Chlamydia trachomatis DNA [Presence] || [|21613-5] || 180 ||  ||   ||   ||   ||   ||   ||
 * 99 || 125 || Microbiology || Chlamydia trachomatis+​Neisseria gonorrhoeae rRNA [Presence] || [|45076-7] || >2017 ||  ||   ||   ||   ||   ||   ||
 * 100 || 126 || Microbiology || Neisseria gonorrhoeae DNA [Presence] || [|24111-7] || 178 ||  ||   ||   ||   ||   ||   ||
 * 101 || 127 || Microbiology || Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] || [|30167-1] || 172 ||  ||   ||   ||   ||   ||   ||
 * 102 || 128 || Microbiology || Human papilloma virus 6+11+42+43+44 DNA [Presence] || [|42481-2] || 557 ||  ||   ||   ||   ||   ||   ||
 * 103 || 129 || Microbiology || Influenza virus A RNA [Presence] || [|34487-9] || >2017 ||  ||   ||   ||   ||   ||   ||
 * 104 || 130 || Microbiology || Influenza virus B RNA [Presence] || [|40982-1] || >2017 ||  ||   ||   ||   ||   ||   ||
 * 105 || 131 || Microbiology || Influenza virus A subtype [Identifier] || [|22827-0] || >2017 ||  ||   ||   ||   ||   ||   ||
 * 106 || 132 || Microbiology || Influenza virus A+​B RNA [Identifier] || [|48509-4] || 201(orders) ||  ||   ||   ||   ||   ||   ||
 * 107 || 133 || Microbiology || Microscopic observation [Identifier] in Unspecified specimen by Gram stain || [|664-3] || 194 ||  ||   ||   ||   ||   ||   ||
 * 108 || 134 || Microbiology || Bacteria identified in Unspecified specimen by Culture || [|6463-4] || 39 ||  ||   ||   ||   ||   ||   ||
 * 109 || 135 || Microbiology || Methicillin resistant Staphylococcus aureus [Presence] || [|13317-3] || 146 ||  ||   ||   ||   ||   ||   ||
 * 110 || 136 || Microbiology || Ova + Parasite [Identifier] microscopy || [|673-4] || 527 ||  ||   ||   ||   ||   ||   ||
 * 111 || 137 || Microbiology || Bordetella pertussis Ag [Presence] || [|550-4] || 1820 ||  ||   ||   ||   ||   ||   ||
 * 112 || 138 || Microbiology || Respiratory Syncytial Virus DNA and RNA [Identifier] || [|40987-0] || >2017 ||  ||   ||   ||   ||   ||   ||
 * 113 || 139 || Microbiology || Rubella IgM [Units/volume] || [|5335-5] || 1961 ||  ||   ||   ||   ||   ||   ||
 * 114 || 140 || Microbiology || Rubella IgG [Units/volume]  || [|5334-8]  || 296  ||   ||   ||   ||   ||   ||   ||
 * 115 || 141 || Microbiology || Rubella IgG [Presence] || [|25514-1]  || >2017 ||   ||   ||   ||   ||   ||   ||
 * 116 || 142 || Microbiology || Rubella IgM [Presence] || [|31616-6]  || >2017 ||   ||   ||   ||   ||   ||   ||
 * 117 || 143 || Microbiology || Virus culture [Identifier] || [|6584-7]  || 655 ||   ||   ||   ||   ||   ||   ||
 * || 163 || Antibacterial susceptibility || Gentamicin [Susceptibility] || 18928-2 || 265 ||  ||   ||   ||   ||   ||   ||
 * || 60 || Anatomic Pathology || Surgical pathology study || 11529-5 || 209 ||  ||   ||   ||   ||   ||   ||
 * || 61-62 || Blood bank || ABO and Rh group panel || 34530-6 || - ||  ||   ||   ||   ||   ||   ||
 * || 1-16 || Chemistry || Comprehensive metabolic 2000 panel || 24323-8 || - ||  ||   ||   ||   ||   ||   ||
 * || 119 || Genetics || CFTR gene mutations found || 21654-9 || 460 ||  ||   ||   ||   ||   ||   ||
 * || 72-99 || Hematology || CBC W Auto Differential panel || 57021-8 || - ||  ||   ||   ||   ||   ||   ||
 * || 102-105 || Hepatitis || Acute Hepatitis panel || 24363-4 || - ||  ||   ||   ||   ||   ||   ||
 * || 158 || Microbiology || Streptococcus.beta-hemolytic || 546-2 || 521 ||  ||   ||   ||   ||   ||   ||
 * || 114-118 || Toxicology || Drugs of abuse 5 panel || 65750-2 || - ||  ||   ||   ||   ||   ||   ||
 * || 166-185 || Urinalysis || Urinalysis panel in Urine || 24356-8 || - ||  ||   ||   ||   ||   ||   ||
 * || 60 || Anatomic Pathology || Surgical pathology study || 11529-5 || 209 ||  ||   ||   ||   ||   ||   ||
 * || 61-62 || Blood bank || ABO and Rh group panel || 34530-6 || - ||  ||   ||   ||   ||   ||   ||
 * || 1-16 || Chemistry || Comprehensive metabolic 2000 panel || 24323-8 || - ||  ||   ||   ||   ||   ||   ||
 * || 119 || Genetics || CFTR gene mutations found || 21654-9 || 460 ||  ||   ||   ||   ||   ||   ||
 * || 72-99 || Hematology || CBC W Auto Differential panel || 57021-8 || - ||  ||   ||   ||   ||   ||   ||
 * || 102-105 || Hepatitis || Acute Hepatitis panel || 24363-4 || - ||  ||   ||   ||   ||   ||   ||
 * || 158 || Microbiology || Streptococcus.beta-hemolytic || 546-2 || 521 ||  ||   ||   ||   ||   ||   ||
 * || 114-118 || Toxicology || Drugs of abuse 5 panel || 65750-2 || - ||  ||   ||   ||   ||   ||   ||
 * || 166-185 || Urinalysis || Urinalysis panel in Urine || 24356-8 || - ||  ||   ||   ||   ||   ||   ||

include component="page" wikiName="siframework" page="space.template.inc_contentleft_end"